Skip to content

Pregnancy, not nevirapine cause of liver toxicities in HIV-positive women

Small case series looks at etravirine during pregnancy

Warning issued about rare etravirine allergic reactions

Discovery of enzyme structure points way to creating less toxic anti-HIV drugs

Stopping efavirenz due to CNS side-effects not associated with blood levels of the drug

Abacavir impairs endothelial function, possibly explaining increased heart attack risk

Inflammation signals heart disease risk in people with HIV

Tobacco, marijuana and alcohol may lower levels of some anti-HIV drugs

d4T dose reduction does not result in poorer treatment outcomes in South African patients